NCPI
NIH Cloud PlatformInteroperability Effort
searchclose
YouYubeGitHubSlack

Study

arrow_backDatasets

PAGE: IPM BioMe Biobank

phs000925.v1.p1dbGapdbGap FHIR

Description

The Institute for Personalized Medicine (IPM) BioMe Biobank is a consented, EMR-linked medical care setting biorepository of the Mount Sinai Medical Center (MSMC) drawing from a population of over 70,000 inpatients and 800,000 outpatient visits annually. MSMC serves diverse local communities of upper Manhattan, including Central Harlem (86% African American), East Harlem (88% Hispanic Latino), and Upper East Side (88% Caucasian/white) with broad health disparities. IPM BioMe Biobank populations include 28% African American, 38% Hispanic Latino predominantly of Caribbean origin, 23% Caucasian/White. IPM BioMe Biobank disease burden is reflective of health disparities with broad public health impact. Biobank operations are fully integrated in clinical care processes, including direct recruitment from clinical sites waiting areas and phlebotomy stations by dedicated Biobank recruiters independent of clinical care providers, prior to or following a clinician standard of care visit. Recruitment currently occurs at a broad spectrum of over 30 clinical care sites.

This study is part of the Population Architecture using Genomics and Epidemiology (PAGE) study (phs000356).

Summary

PlatformsAnVIL
Consent CodesNRUP, GRU
Focus / DiseasesCardiovascular Diseases
Study DesignProspective Longitudinal Cohort
Data TypesSNP Genotypes (Array), WGS
Subjects13,067